DCIS | Invasive carcinoma of breast Estrogen receptor positive TNM Breast tumor staging | Invasive carcinoma of breast Progesterone receptor positive TNM Breast tumor staging | Immunohistochemistry | Aromatase Inhibitors considering | Tamoxifen | Adjuvant Chemotherapy Completed | Preoperative Chemotherapy
Item
patients with histologically proven dcis or stage i-iii invasive carcinoma of the breast that is estrogen and/or progesterone receptor positive by immunohistochemical staining who are considering aromatase inhibitor therapy; women may receive the ai on this study as initial adjuvant hormonal treatment or following tamoxifen; patients must have completed any adjuvant chemotherapy; patients may have received preoperative chemotherapy
boolean
C0007124 (UMLS CUI [1])
C0853879 (UMLS CUI [2,1])
C0279754 (UMLS CUI [2,2])
C0474926 (UMLS CUI [2,3])
C0853879 (UMLS CUI [3,1])
C0279759 (UMLS CUI [3,2])
C0474926 (UMLS CUI [3,3])
C0021044 (UMLS CUI [4])
C0593802 (UMLS CUI [5,1])
C0750591 (UMLS CUI [5,2])
C0039286 (UMLS CUI [6])
C0085533 (UMLS CUI [7,1])
C0205197 (UMLS CUI [7,2])
C2347669 (UMLS CUI [8])
Postmenopausal state | Age | Amenorrhea | Uterus Intact | Both ovaries Intact | Follicle stimulating hormone measurement | Estradiol measurement | Uterus Absent | Bilateral oophorectomy | Radiation castration | Pharmaceutical Preparations Suppressing Ovarian function
Item
postmenopausal status, defined as: >= 60 years of age; or < 60 years of age and amenorrheic for >= 12 months prior to day 1 if intact uterus/ovaries; or < 60 years of age, and the last menstrual period 6-12 months prior to day 1, if intact uterus/ovaries and meets biochemical criteria for menopause (fsh and estradiol within institutional standards for postmenopausal status); or < 60 years of age, without a uterus, and meets biochemical criteria for menopause (fsh and estradiol within institutional standards for postmenopausal status); or < 60 years of age and history of bilateral oophorectomy; or prior radiation castration with amenorrhea for at least 6 months; < 60 years of age and taking medication designed to suppress ovarian function and meets biochemical criteria for menopause (estradiol levels within institutional standards for postmenopausal status; women would have had to be taking the drug for at least 30 days prior to day 1)
boolean
C0232970 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0002453 (UMLS CUI [3])
C0042149 (UMLS CUI [4,1])
C0205266 (UMLS CUI [4,2])
C0227898 (UMLS CUI [5,1])
C0205266 (UMLS CUI [5,2])
C0202022 (UMLS CUI [6])
C0337434 (UMLS CUI [7])
C0042149 (UMLS CUI [8,1])
C0332197 (UMLS CUI [8,2])
C0278321 (UMLS CUI [9])
C0877129 (UMLS CUI [10])
C0013227 (UMLS CUI [11,1])
C1260953 (UMLS CUI [11,2])
C0678879 (UMLS CUI [11,3])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Comprehension Study Protocol | Informed Consent
Item
patient is aware of the nature of her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
Exclusion Criteria
Item
exclusion
boolean
C0680251 (UMLS CUI [1])
Hormone replacement therapy
Item
concurrent use of hormone replacement therapy
boolean
C0282402 (UMLS CUI [1])
Tamoxifen | Tamoxifen To be stopped
Item
concurrent use of tamoxifen; patients taking tamoxifen must discontinue the drug prior to first dose of zoledronic acid
boolean
C0039286 (UMLS CUI [1])
C0039286 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
Selective Estrogen Receptor Modulators | Raloxifene
Item
concurrent use of other selective estrogen receptor modulator (serm) such as raloxifene
boolean
C0732611 (UMLS CUI [1])
C0244404 (UMLS CUI [2])
Consumption Soy Supplements
Item
concurrent consumption of soy supplements; routine dietary consumption of soy containing foods will be permitted
boolean
C0009830 (UMLS CUI [1,1])
C0037733 (UMLS CUI [1,2])
C0242295 (UMLS CUI [1,3])
Aromatase Inhibitors Previous
Item
prior use of an aromatase inhibitor in any setting
boolean
C0593802 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Diphosphonates Oral | Diphosphonates Intravenous
Item
current bisphosphonate use (oral or intravenous); prior bisphosphonate users would be eligible as long as the use was > 1 month ago for oral bisphosphonates and/or > 12 months ago for intravenous bisphosphonates, prior to starting study treatment
boolean
C0012544 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0012544 (UMLS CUI [2,1])
C1522726 (UMLS CUI [2,2])
Renal Insufficiency Moderate | Renal Insufficiency Severe | Creatinine measurement, serum | Creatinine clearance measurement
Item
moderate to severe renal impairment (serum creatinine greater than 2 mg/dl or creatinine clearance less than 50 ml/min)
boolean
C1565489 (UMLS CUI [1,1])
C0205081 (UMLS CUI [1,2])
C1565489 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0201976 (UMLS CUI [3])
C0373595 (UMLS CUI [4])
Hypersensitivity Letrozole | Zoledronic acid allergy | Hypersensitivity Letrozole Excipient | Hypersensitivity Zoledronic acid Excipient
Item
hypersensitivity to letrozole or zoledronic acid or any of its excipients
boolean
C0020517 (UMLS CUI [1,1])
C0246421 (UMLS CUI [1,2])
C4544924 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0246421 (UMLS CUI [3,2])
C0015237 (UMLS CUI [3,3])
C0020517 (UMLS CUI [4,1])
C0257685 (UMLS CUI [4,2])
C0015237 (UMLS CUI [4,3])
Adrenal Cortex Hormones Oral | Adrenal Cortex Hormones Intravenous
Item
concomitant treatment with oral or intravenous corticosteroids
boolean
C0001617 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0001617 (UMLS CUI [2,1])
C1522726 (UMLS CUI [2,2])
Tooth problem | Infection of tooth | infection jaw | Maxilla infection | Lower jaw bone infection | Dental trauma | Fixture Trauma | Osteonecrosis of jaw | Exposed bone in jaw | Healing Slow | Status post Dental Procedure
Item
current active dental problems including infection or the teeth or jawbone (maxilla or mandibular); dental or fixture trauma, or a current or prior diagnosis of osteonecrosis of the jaw (onj), of exposed bone in the mouth, or of slow healing after dental procedures
boolean
C0576962 (UMLS CUI [1])
C0877046 (UMLS CUI [2])
C1400570 (UMLS CUI [3])
C1400602 (UMLS CUI [4])
C1290708 (UMLS CUI [5])
C1301685 (UMLS CUI [6])
C3879289 (UMLS CUI [7,1])
C3714660 (UMLS CUI [7,2])
C2711248 (UMLS CUI [8])
C3160827 (UMLS CUI [9])
C0043240 (UMLS CUI [10,1])
C0439834 (UMLS CUI [10,2])
C0231290 (UMLS CUI [11,1])
C0011331 (UMLS CUI [11,2])
Dental surgical procedure | Dental surgical procedure Planned | Jaw Surgery | Jaw Surgery Planned | Tooth Extraction | Dental Implants
Item
recent (within 6 weeks) or planned dental or jaw surgery (e.g. extraction, implants)
boolean
C0204324 (UMLS CUI [1])
C0204324 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C0407713 (UMLS CUI [3])
C0407713 (UMLS CUI [4,1])
C1301732 (UMLS CUI [4,2])
C0040440 (UMLS CUI [5])
C0376511 (UMLS CUI [6])